3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
66
Lymphoma, Follicular
21
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Mantle-Cell
10
Lymphoma
10
Recurrence
7
Lymphoma, B-Cell, Marginal Zone
7
Neoplasms, Plasma Cell
6
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Smoldering Multiple Myeloma
3
Neoplasms
3
Neuroblastoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Lenalidomide
×
90 days
×
Clear all
No trials found.